Cognitive health used to be a seniors’ category. Today students, working professionals, older adults and parents are all shopping for it, and Pycnogenol® has published research that speaks to each of them.
Spend an afternoon in almost any natural health store this fall and you will see brain-health shoppers of every age. A university student is stocking up before midterms. A manager in her mid-forties wants something for the afternoon slump. A retiree hopes to stay as sharp as the people she plays bridge with, and a father has questions about his son’s focus at school. A few years ago, the retiree would probably have been the only one in that aisle. Most stores still serve these customers with different products in different parts of the store.
For brands, a wider customer base is good news, but only for ingredients that have research at more than one stage of life. On September 23, Horphag Research outlined the cognitive research behind Pycnogenol®, its standardized French maritime pine bark extract, with published studies in children, students, working professionals and older adults. Horphag says the extract has been studied in more than 160 clinical trials across all areas of health. For retailers, the appeal is practical. A single, well-documented ingredient can earn a place in more than one section of the store, and staff can talk about it with confidence wherever a customer comes across it.
| Life stage | What the research looked at | Where this customer shops | How the store can respond |
|---|---|---|---|
| Children | Children with ADHD, compared with methylphenidate and placebo over ten weeks | At the counter, usually a parent with a question | Refer to the pharmacist or family doctor, with the study on hand |
| Students | Healthy students aged 18 to 27 over eight weeks | Exam season, energy and focus | Staff knowledge and a seasonal feature |
| Working professionals | Healthy adults aged 35 to 55 with high oxidative stress over twelve weeks | Stress, energy and antioxidants | Staff knowledge and a second shelf location |
| Older adults | Healthy adults aged 60 to 85 in a double-blind, placebo-controlled trial over three months | Healthy aging | The main shelf location and the core staff message |
Older adults: the strongest place to start
The most rigorous of the four studies was carried out at Swinburne University of Technology in Australia and published in the Journal of Psychopharmacology in 2008. Researchers recruited 101 healthy adults between 60 and 85 and matched them in pairs by age, sex, body mass, diet and intelligence. Half took 150 mg of Pycnogenol® daily for three months while the other half took a placebo. Neither the participants nor the researchers knew who was getting which.
By the end of the study, the Pycnogenol group had improved significantly on memory tasks, particularly spatial and numeric working memory. Their blood work also showed lower levels of F2-isoprostanes, a marker of oxidative damage, which fits with the antioxidant activity Horphag describes. This is the study staff should know best. The participants were healthy, the trial was blinded, and the researchers measured a change in the blood as well as on the tests. A customer in her sixties will usually respond better to who was studied and what they found than to a word like “supports” on a shelf-talker.
Students and working professionals: where the category is growing
These two groups are where cognitive health is growing fastest, and where many stores have yet to find the right way in.
In an eight-week observational study published in Panminerva Medica in 2011, 53 healthy students aged 18 to 27 who took Pycnogenol® scored better than a comparison group on tests of sustained attention, memory and executive function. Their average exam marks were 7.6 per cent higher, and they failed fewer exams. A twelve-week study of healthy professionals aged 35 to 55, published in the Journal of Neurosurgical Sciences in 2014, reported gains in attention, memory, executive function and mood, as well as better scores on everyday work tasks. Plasma free radicals in the Pycnogenol group dropped by a median of 30.4 per cent.
Neither study used a placebo. Both compared people taking the extract with similar people who were not, so they work best as supporting evidence next to the older-adult trial. What they give a retailer is a broader audience. The same product can now be part of a conversation with a customer in her forties as well as one in her sixties.
Dr. Fred Pescatore, a physician and author, made the same point in Horphag’s announcement. “People often don’t start thinking seriously about cognitive health until they’re older, but focus, memory and mental stamina matter much earlier in life,” he said.
Children: a conversation for the pharmacist
The research in children shows where scientific interest is heading, and it needs the most care in store. In a ten-week, double-blind randomized trial at the University of Antwerp, published in the Journal of Functional Foods in 2022, 88 children with ADHD were given Pycnogenol®, methylphenidate or a placebo. Teachers reported significant improvement in overall ADHD symptoms, and in hyperactivity and impulsivity, among the children taking Pycnogenol compared with placebo. Side effects were reported far more often with methylphenidate.
Some parents will have read about this study before they walk in. Because ADHD is a diagnosed condition, the question belongs with the pharmacist or the child’s doctor. Having the reference printed and ready, and offering to make the introduction, shows the parent that the store is taking the question seriously. It is also a good reason for the pharmacist and front-shop staff to agree ahead of time on how they will handle it.
What the shelf can say
Talking about research and printing claims are two different things. In Canada, anything on a sign or shelf-talker has to match the product’s licence. Licensed Pycnogenol® products carry specific approved wording, including relief of perimenopausal symptoms such as poor concentration and focus. In practice, staff can describe what the studies found and who took part, while printed material sticks to the licence.
Questions to ask your Pycnogenol® representative
- Which daily dose did each cognitive study use, and how do the directions on our products compare? The older-adult and professional studies both used 150 mg a day, which helps staff answer questions about serving size.
- Which licensed claims does each of our Pycnogenol products carry? If a product sits in more than one section of the store, the signage in each spot needs to match what is on that box.
- Is there point-of-sale material that summarizes the older-adult trial in approved language? A short card saves stores from writing their own and keeps the description consistent.
Over the next few years, more brands are likely to launch cognitive products aimed at specific life stages, from formats for children to blends for adults over 60. The ingredients that hold their place in those lines will be the ones with research at each stage and licences to match. Retailers who sort out shelf placement and staff training now will be ready when those products arrive.
Frequently asked questions
How long should a customer take Pycnogenol® before judging the results?
The older-adult trial assessed participants every month, not just at the end. In the children’s trial, methylphenidate showed results by week five, while the teacher-rated effects of Pycnogenol built up later in the ten weeks. Canadian labels advise speaking with a practitioner about use beyond three months, which is a natural time for a follow-up conversation.
What do Canadian dosing directions say?
Licensed Canadian 100 mg products direct one capsule a day for antioxidant, inflammation-marker and knee osteoarthritis uses, and one capsule twice a day for perimenopause symptoms. Directions vary by product and licence, so staff should check the specific box.
Where does Pycnogenol come from?
It is extracted from the bark of French maritime pine trees grown in managed forests in the Landes region of southwest France. It is standardized to a consistent profile of procyanidins, bioflavonoids and phenolic acids, which is why the research on Pycnogenol applies to Pycnogenol specifically and not to generic pine bark extracts.
Retailers should confirm each product’s NPN and licensed claim wording before making signage or marketing decisions.
Sources: Horphag Research, “Pycnogenol® Offers Clinically Backed Cognitive Support Across Generations,” GlobeNewswire, September 23, 2026. Weyns A-S et al., Journal of Functional Foods, 2022. Luzzi R et al., Panminerva Medica 2011;53(3 Suppl 1):75-82. Belcaro G et al., Journal of Neurosurgical Sciences 2014;58(4):239-48. Ryan J et al., Journal of Psychopharmacology 2008;22(5):553-62, doi:10.1177/0269881108091584. Natural Factors Canada, Pycnogenol 100 mg product listing.
